Melanoma biomarkers: current status and vision for the future

被引：0
作者：
Allison R Larson
Eliz Konat
Rhoda M Alani
机构：
[1] AR Larson is a Medical Student,
[2] E Konat is a Graduate Student,undefined
[3] and RM Alani is Associate Professor in Oncology,undefined
[4] The Sidney Kimmel Comprehensive Cancer Center,undefined
[5] Johns Hopkins University School of Medicine,undefined
[6] Baltimore,undefined
[7] MD,undefined
[8] USA.,undefined
来源：
Nature Clinical Practice Oncology | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Melanoma is the leading cause of death by skin cancer in industrialized countries. Identification of tumor markers may help to define molecular pathways involved in melanoma development and progression, and identify patients with early-stage melanoma who would benefit from additional therapies. Larson et al. overview the melanoma biomarkers that are most helpful for predicting patient outcomes, and discuss the biomarkers that have demonstrated prognostic significance independent of primary tumor thickness and other common clinical prognostic indicators.
引用
收藏
页码：105 / 117
页数：12
相关论文
共 89 条
[1]  
Slingluff CL(1988)Lethal “thin” malignant melanoma. Identifying patients at risk Ann Surg 208 150-161
[2]  
Balch CM(2001)Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 3622-3634
[3]  
Bosserhoff AK(2006)Novel biomarkers in malignant melanoma Clin Chim Acta 367 28-35
[4]  
Ilmonen S(2005)Ki-67, Bcl-2, and p53 expression in primary and metastatic melanoma Melanoma Res 15 375-381
[5]  
Carlson JA(2005)Molecular diagnostics in melanoma J Am Acad Dermatol 52 743-775
[6]  
Alonso SR(2004)Progression in cutaneous malignant melanoma is associated with distinct expression profiles Am J Pathol 164 193-203
[7]  
Väisänen A(1998)Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma J Pathol 186 51-58
[8]  
Dai DL(2005)Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases J Clin Oncol 23 1473-1482
[9]  
Thies A(2002) expression in cutaneous malignant melanoma predicts the development of metastatic disease J Clin Oncol 20 2530-2536
[10]  
Scala S(2005)Expression of Clin Cancer Res 11 1835-1841
123456789